Back to search

Frequency of blood CX3CR1‐positive natural killer cells correlates with disease activity in multiple sclerosis patients

Data up to Jan 2025

Published2005
Citations86
References42

Total Citations Per Year

Abstract

References (42)

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

2001 • 6,888 citations

Multiple Sclerosis

2000 • 2,813 citations

The biology of human natural killer-cell subsets

2001 • 2,801 citations

A new class of membrane-bound chemokine with a CX3C motif

1997 • 1,964 citations

Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

1998 • 679 citations

Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells

1997 • 360 citations

Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression

2002 • 320 citations

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses

2001 • 318 citations

Fractalkine in Vascular Biology

2003 • 306 citations

Multiple sclerosis

2004 • 305 citations

Calcein-Acetyoxymethyl Cytotoxicity Assay: Standardization of a Method Allowing Additional Analyses on Recovered Effector Cells and Supernatants

2001 • 296 citations

Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction

1999 • 242 citations

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS

2002 • 233 citations

Fractalkine and fractalkine receptors in human neurons and glial cells

2002 • 226 citations

Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease

2003 • 214 citations

Cutting Edge: Molecular Portrait of Human Autoimmune Disease

2002 • 206 citations

Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes

2001 • 179 citations

Selective lymphocyte chemokine receptor expression in the rheumatoid joint

2001 • 173 citations

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

1980 • 167 citations

A high-density probe array sample preparation method using 10- to 100-fold fewer cells

1999 • 160 citations

Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity

2004 • 159 citations

Migration of CX3CR1‐positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis

2002 • 155 citations

Key issues in the diagnosis and treatment of multiple sclerosis

2002 • 153 citations

The regulatory role of natural killer cells in multiple sclerosis

2004 • 132 citations

Natural killer type 2 bias in remission of multiple sclerosis

2001 • 123 citations

The Role of NK Cells in Autoimmune Disease

2002 • 118 citations

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects

2001 • 110 citations

The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity

1997 • 99 citations

A role for natural killer cells in the immunopathogenesis of multiple sclerosis

1998 • 95 citations

CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system

2003 • 93 citations

CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis

2003 • 87 citations

Clinical relapses of multiple sclerosis are associated with ‘novel’ valleys in natural killer cell functional activity

2003 • 86 citations

Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: Possible contribution to skin inflammation

2004 • 83 citations

Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.

1982 • 83 citations

Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells

2004 • 66 citations

Membrane‐bound form of fractalkine induces IFN‐γ production by NK cells

2002 • 61 citations

Roles of CCR2 and CXCR3 in the T cell–mediated response occurring during lupus flares

2003 • 55 citations

Natural killer cell number and activity in multiple sclerosis

1989 • 50 citations

Key issues in the diagnosis and treatment of multiple sclerosis

2002 • 49 citations

Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2

1985 • 28 citations

Natural killer cells: emerging concepts in immunity to infection and implications for assessment of immunodeficiency

2003 • 12 citations

Cited By (0)

Loading...
Frequency of blood CX3CR1‐positive natural killer cells correlates with disease activity… (2005) – The FASEB Journal | Metascience Observatory Explorer